|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| C12Q 1/37 | |||
| A61K 38/48 | |||
| C12N 9/68 |
| (11) | Number of the document | 2661493 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12700154.3 |
| Date of filing the European patent application | 2012-01-04 | |
| (97) | Date of publication of the European application | 2013-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/050074 |
| Date | 2012-01-04 |
| (87) | Number | WO 2012/093132 |
| Date | 2012-07-12 |
| (30) | Number | Date | Country code |
| 11150246 | 2011-01-05 | EP | |
| 201161429868 P | 2011-01-05 | US |
| (72) |
ZWAAL, Richard Reinier, BE
|
| (73) |
ThromboGenics N.V.,
Gaston Geenslaan 1, 3001 Heverlee,
BE
|
| (54) | PLASMINOGEN AND PLASMIN VARIANTS |
| PLASMINOGEN AND PLASMIN VARIANTS |